Miami Lakes, FL

Elizabeth Jimenez

Angels Clinical Research Institute

COVID-19

Psychotic Disorders

Human Influenza

Alzheimer Disease

Atopic Dermatitis

KarXT

Rocatinlimab

AMG 451

S-309309

Obeldesivir

Amgen

BioNTech

Gilead Sciences

Karuna Therapeutics

Shionogi

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Angels Clinical Research Institute | Miami Lakes, FL

Site insights

Contact this site

Active trials

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Trial sponsors